Tag: Richard Pazdur

AstraZeneca gets FDA approval for Tagrisso for type of NSCLC

pharmanewsdaily- December 19, 2020

AstraZeneca has secured extended approval from the US Food and Drug Administration for using Tagrisso (osimertinib) as an adjuvant treatment of non-small cell lung cancer ... Read More

FDA approves BMS’ Opdivo, Yervoy combo for malignant pleural mesothelioma

pharmanewsdaily- October 4, 2020

Bristol Myers Squibb (BMS) has secured approval for Opdivo (nivolumab) and Yervoy (ipilimumab) combination from the US Food and Drug Administration (FDA) for the first-line ... Read More

Deciphera gets Qinlock FDA approval for fourth-line advanced GIST

pharmanewsdaily- May 17, 2020

Qinlock FDA approval : Deciphera Pharmaceuticals has been granted approval from the US Food and Drug Administration (FDA) for Qinlock (ripretinib) in advanced gastrointestinal stromal ... Read More

Selpercatinib FDA approval : Lilly’s therapy approved for treatment of lung and thyroid cancers with RET alteration

pharmanewsdaily- May 9, 2020

Selpercatinib FDA approval : The US Food and Drug Administration (FDA) has approved Eli Lilly and Company's Retevmo (selpercatinib) capsules for the treatment of three ... Read More

Incyte bags Pemazyre FDA approval for cholangiocarcinoma treatment

pharmanewsdaily- April 18, 2020

Pemazyre FDA approval : US biopharma company Incyte has bagged accelerated approval from the US Food and Drug Administration (FDA) for Pemazyre (pemigatinib) for the ... Read More

Astellas, Seattle Genetics bag Padcev FDA approval for advanced urothelial cancer

pharmanewsdaily- December 19, 2019

Padcev FDA approval : Astellas Pharma and Seattle Genetics have bagged accelerated approval from the US Food and Drug Administration (FDA) for Padcev (enfortumab vedotin-ejfv) ... Read More

Global Blood Therapeutics bags Oxbryta FDA approval for sickle cell disease

pharmanewsdaily- November 27, 2019

Oxbryta FDA approval : Global Blood Therapeutics (GBT), a California-based biopharma company, has bagged approval for Oxbryta (voxelotor) tablets from the US Food and Drug ... Read More

Celgene, Acceleron bag Reblozyl FDA approval for anemia in beta thalassemia

pharmanewsdaily- November 9, 2019

Reblozyl FDA approval : Celgene and Acceleron Pharma have bagged approval from the US Food and Drug Administration (FDA) for Reblozyl (luspatercept-aamt) for the treatment ... Read More

Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men

pharmanewsdaily- April 17, 2019

New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer breast cancer drug Ibrance (palbociclib) to cover ... Read More

Seattle Genetics’ Adcetris gets FDA approval for peripheral T-cell lymphoma

pharmanewsdaily- November 18, 2018

Adcetris FDA approval : Seattle Genetics has secured new approval from the US Food and Drug Administration (FDA) for its monoclonal antibody Adcetris (brentuximab vedotin), ... Read More